CHAMGAP
APPROVEDReviewed and approved by the Chamgap Editorial Team (2026-08-08). The draft was written by AI, the existence of all 2 cited sources was verified at the original page, and the verdict passed blind grading and adversarial audit. Methodology v0.7.
Verdict No. 2433 · Search date 2026-08-08 · Methodology v0.7

0.12% to 0.2% chlorhexidine rinse or 0.2% intrasocket gel,
does it really help with Prevention of alveolar osteitis, or dry socket, after tooth extraction?

30-Second Summary
B
Evidence Grade B · 70 · Safety caution
Both rinse and intrasocket gel reduce dry socket, while absolute benefit depends on extraction risk
Rinse can cause tooth or tongue staining, taste disturbance, stomatitis, and oral irritation. Rare immediate allergy and anaphylaxis have been reported; anyone with a previous chlorhexidine reaction should avoid it and seek emergency care for breathing difficulty or facial swelling.
What the
research shows
The grade is B. In the Cochrane review, 0.12% to 0.2% rinse used before extraction and from 24 hours afterward reduced dry socket versus placebo in six trials with 1,547 participants, OR 0.38 (95% CI 0.25 to 0.58), I-squared 48%. A single 0.2% gel application in the socket reduced events in seven trials with 753 participants, OR 0.44 (0.27 to 0.71), I-squared 44%. In the largest 0.12% rinse trial, 10/372 (2.69%) versus 27/372 (7.26%) analyzed patients developed dry socket, absolute reduction 4.57 points (1.5 to 7.7), NNT 21.88 (13.0 to 69.3).
What the
ads claim
'Use a rinse after extraction' is underspecified. Evidence-based regimens used 0.12% or 0.2% rinse before and after surgery for roughly seven days, or one dentist-applied 0.2% intrasocket gel dose. This is not 2% endodontic solution or indefinite self-use.
*

Useful facts when choosing a product

  • Rinses were generally 0.12% to 0.2%, while intrasocket gel was mainly 0.2%; formulation and timing differ.
  • Dry socket was generally diagnosed by severe pain two to three days after extraction with partial or complete clot loss, sometimes with exposed bone or halitosis.
  • Verdict 828 is B with 62 points for chlorhexidine mouthrinse reducing plaque and gingivitis. This verdict addresses the separate indication of post-extraction dry socket.
Gap Measurement · Verdict 2433 · B 70
What advertising claims
What independent, higher-quality research supports
△ GAP
01

What the research actually shows

The 2022 Cochrane review included 39 prevention trials with 6,219 participants and 10 treatment trials with 552. In Halabi's 744-person analysis, high-risk patients undergoing maxillary or mandibular extraction used 15 mL of 0.12% rinse for 30 seconds twice daily for seven days, beginning 24 hours after extraction, versus sterile-water placebo. A total of 822 people were assessed for eligibility; 78 were excluded at that stage, after which 744 were allocated 372 per group and analyzed. The primary endpoint required increasing pain within and around the socket for four postoperative days plus partial or total clot breakdown, with or without exposed bone. The report called the trial double-blind, but blinding of the alveolar-osteitis assessor could not be confirmed. Gel trials mainly placed 0.2% gel once in the socket immediately after extraction and before suturing, versus placebo gel, placebo dressing, or no treatment. Halabi was self-funded by the authors, but funding for every other pooled trial could not be directly verified, so full independent replication was not assigned.

02

Why this is classified as B (70)

Six rinse trials and seven gel trials showed direct event reductions versus placebo, including an absolute reduction in a large individual trial, but blinding of the alveolar-osteitis assessor was not confirmed and populations were concentrated in third-molar surgery. The result is B with 70 points.

Counterpoint. Direct evidence is insufficient to claim that rinse is superior to gel or vice versa. A dental professional should select formulation and schedule based on extraction type, allergy, and baseline risk.

Rejudgment record. Cross-check applied — Separated rinse and intrasocket-gel concentrations and schedules and combined Cochrane estimates with absolute events from the 744-person trial

Scoring profile behind this grade
EndpointHHard endpoint - actual events such as death
ReplicationR1Single confirmatory trial
IndependenceI1Mixed funding sources
Effect sizeE+Meets the clinically important threshold

The scoring table and the verdict agree (B).

Sub-claim grades by effect

This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.

Effect (sub-claim)GradeBasis
Prevention of dry socket with 0.12% to 0.2% rinseBSix trials with 1,547 participants found OR 0.38 (0.25 to 0.58), I-squared 48%.
Prevention of dry socket with 0.2% intrasocket gelBSeven trials with 753 participants found OR 0.44 (0.27 to 0.71), I-squared 44%.
Gel is superior to rinseDDirect comparison gave RR 0.74 (0.46 to 1.20), so superiority was not established.

Cross-check — Codex and Claude

This verdict was drafted by Codex through literature review and source-existence checks, cross-checked through blind grading and adversarial audit, and settled by reapplying the methodology boundary rules. Cases with split grades were resolved through rejudgment.
03

Evidence Table

StudyDesignSampleFundingEndpointResultWeight
Study 1Systematic review of randomized local interventions after extraction753NIHR Cochrane Infrastructure funding; individual trial funding was mixed or unavailableClinically diagnosed dry socket at approximately seven daysRinse OR 0.38 (95% CI 0.25 to 0.58), I-squared 48%; gel OR 0.44 (0.27 to 0.71), I-squared 44%; gel versus rinse RR 0.74 (0.46 to 1.20), two trials and 383 participants.Pivotal pooled direct-event evidence
Study 2Risk-stratified double-blind placebo-controlled randomized trial372Self-funded by the authors; no conflicts declaredAlveolar osteitis defined by increasing pain for four days around the socket plus partial or total clot breakdown0.12% rinse 10/372 (2.69%) versus sterile-water placebo 27/372 (7.26%); absolute reduction 4.57 points (95% CI 1.5 to 7.7), NNT 21.88 (13.0 to 69.3), P=.006.Largest individual rinse trial with absolute event data
§

Receipt — 2 References

All 2 cited sources were verified for existence at the original page (as of 2026-08-08).

Daly BJM, Sharif MO, Jones K, Worthington HV, Beattie A. Local interventions for the management of alveolar osteitis (dry socket). Cochrane Database Syst Rev. 2022;9:CD006968. PMID: 36156769. DOI: 10.1002/14651858.CD006968.pub3.
checked
Halabi D, Escobar J, Alvarado C, Martinez N, Muñoz C. Chlorhexidine for prevention of alveolar osteitis: a randomised clinical trial. J Appl Oral Sci. 2018;26:e20170245. PMID: 29742264. DOI: 10.1590/1678-7757-2017-0245.
checked
Draft and rewrite: Codex (AI) · Verification: Codex blind grading and adversarial audit · Final adjudication: Claude
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-08-08 · Corrections: none

Cite this verdict

0.12% to 0.2% chlorhexidine rinse or 0.2% intrasocket gel x prevention of dry socket Evidence Grade B card
[Chamgap] 0.12% to 0.2% chlorhexidine rinse or 0.2% intrasocket gel x prevention of dry socket — Evidence Grade B·70. 2 cited sources checked. Source: https://chamgap.com/en/verdicts/general/chlorhexidine-rinse-gel-dry-socket-prevention-after-extraction/ · CC BY 4.0

CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.

!

What this document does and does not do

Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.